Jaraa'idJaraa'id
Notification Show More
Latest News
U-20 World Cup draw in Bali postponed amid protest against Israel participation
Asia
China’s economic rebound weaker than expected, warns Maersk
Business
Dusty Henricksen grabs slopestyle Crystal Globe, Taiga Hasegawa signs off season with victory
Sports
North Korea fires ballistic missile: Seoul
Asia
Panama warns of surge in US-bound migration through deadly jungle
Business
Aa
  • Home
  • Local News
  • Africa
  • United States
  • Europe
  • Asia
  • Sports
  • Videos
  • Live Score
  • More
    • Business
    • Market Data
      • Stocks
      • Commodities
      • Cryptocurrency
      • Forex
    • Weather
Reading: Pfizer set to buy oncology-focused biotech SeaGen in $43bn deal
Share
Aa
Jaraa'idJaraa'id
  • Somalia
  • Africa
  • United States
  • Europe
  • Asia
  • Business
  • Sports
  • Videos
Search
  • Home
  • Local News
  • Videos
  • World
    • Africa
    • United States
    • Europe
    • Asia
  • Market Data
    • Stocks
    • Commodities
    • Cryptocurrency
    • Forex
  • More
    • Sports
    • Business
    • Weather
    • Live Score
Have an existing account? Sign In
Follow US
Jaraa'id > Business > Pfizer set to buy oncology-focused biotech SeaGen in $43bn deal
Business

Pfizer set to buy oncology-focused biotech SeaGen in $43bn deal

News Room
Last updated: 2023/03/13 at 12:34 PM
News Room Published March 13, 2023
Share
SHARE

Pfizer plans to acquire oncology-focused biotech SeaGen for a total enterprise value of $43bn as the US pharmaceutical company refills its drugs pipeline.

Albert Bourla, Pfizer’s chief executive, said it is “deploying its financial resources to advance the battle against cancer”.

Pfizer has agreed to buy SeaGen for $229 in cash per share, funding the transaction through $31bn of new long-term debt, as well short-term financing and cash.

In 2023, SeaGen expects revenue of about $2.2bn, a 12 per cent rise year on year. In 2030, Pfizer believes SeaGen could contribute more than $10bn in risk-adjusted revenues.

Merck was in talks to acquire SeaGen last summer, offering about $200 per share, according to people familiar with the matter.

Any deal would have to pass antitrust scrutiny in the US, where the Biden administration has tightened scrutiny of pharmaceutical mergers as it aims to drive down drug prices.

Analysts said a tie-up between Pfizer and SeaGen would be unlikely to provoke a negative response from the Federal Trade Commission given there is limited overlap between the companies’ products.

“We see no FTC concerns, as Pfizer does not have an antibody-drug conjugate or even a major antibody-based oncology platform,” said Evan Seigerman, analyst at BMO Capital Markets.

Read the full article here

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
I have read and agree to the terms & conditions
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
News Room March 13, 2023
Share this Article
Facebook Twitter Email Print
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular News
Asia

U-20 World Cup draw in Bali postponed amid protest against Israel participation

News Room News Room March 27, 2023
China’s economic rebound weaker than expected, warns Maersk
Dusty Henricksen grabs slopestyle Crystal Globe, Taiga Hasegawa signs off season with victory
North Korea fires ballistic missile: Seoul
Panama warns of surge in US-bound migration through deadly jungle
Carlos Alcaraz flattens Dusan Lajovic to set up last-16 clash with Tommy Paul at Miami Open
Jay Powell and Janet Yellen struggle to calm nerves in banking crisis
Next Tottenham Hotspur manager: Mauricio Pochettino to return? Julian Nagelsmann or Luis Enrique?
- Advertisement -
Ad imageAd image

You Might also Like

Business

China’s economic rebound weaker than expected, warns Maersk

March 27, 2023
Business

Panama warns of surge in US-bound migration through deadly jungle

March 27, 2023
Business

Jay Powell and Janet Yellen struggle to calm nerves in banking crisis

March 26, 2023
Business

Air India boss hails biggest turnround effort in airline’s history

March 26, 2023
  • Somalia
  • Africa
  • United States
  • Europe
  • Asia
  • Cryptocurrency
  • Forex
  • Stock Market

About US

Jaraa'id is your one-stop website for the latest global and local news and updates, follow us now to get the news that matters to you.
Quick Link
  • Privacy Policy
  • Terms of use
  • Press ReleaseSubmit
  • Advertise
  • Contact
Top Sections
  • Business
  • Sports
  • Videos
  • Market DataLive
  • Weather

Subscribe US

Subscribe to our newsletter to get our Latest articles instantly!

I have read and agree to the terms & conditions

2023 © Jaraa'id. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?